Newsfiscal.ai
Coherus Oncology Announces Interim Clinical Data for Tagmokitug in Esophageal Cancer
· Published
Article summary
Coherus Oncology reported encouraging interim clinical data from its TREGCHECK development program, showing anti-tumor activity for tagmokitug in combination with toripalimab for solid tumors.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…